FDA approves larger Nelarabine vial size for T-ALL and T-LBL
The United States Food and Drug Administration (FDA) has signed off on a new, larger vial size for Nelarabine Injection.
Smoldering MM trends data show increased incidence in certain patient populations
Kerri Fitzgerald
February 3, 2026
A Letter to the Editor published in the American Journal of Hematology by Rong Wang, PhD, of Yale University, and colleagues is the “first study” to show smoldering multiple myeloma (SMM) incidence in the United States using cancer registry da
